Concourse Financial Group Securities, Inc. Sorrento Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.52 Billion
  • Q1 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
N/A
0 New
0 $0
Q4 2023

Feb 07, 2024
BUY
N/A
0 New
0 $0
Q3 2023

Oct 30, 2023
BUY
N/A
0 New
0 $0
Q3 2023

Oct 25, 2023
SELL
N/A
-25 Closed
0 $0
Q1 2023

May 15, 2023
BUY
$0.17 - $1.19 $4 - $29
25 New
25 $0
Q4 2022

Jan 30, 2023
BUY
$0.74 - $1.83 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$1.51 - $2.88 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.24 - $2.33 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
SELL
$2.0 - $4.9 $4,100 - $10,045
-2,050 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$5.76 - $11.95 $1,728 - $3,585
-300 Reduced 12.77%
2,050 $14,000
Q3 2020

Nov 13, 2020
BUY
$6.17 - $18.82 $1,851 - $5,646
300 Added 14.63%
2,350 $26,000
Q2 2020

Aug 13, 2020
BUY
$1.73 - $6.76 $3,546 - $13,858
2,050 New
2,050 $13,000
Q1 2020

May 13, 2020
BUY
$1.57 - $4.76 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.45 - $4.17 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$2.05 - $2.69 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$2.67 - $4.38 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$1.86 - $5.94 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$2.01 - $4.24 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$4.22 - $7.5 $0 - $0
0 New
0 $0

Others Institutions Holding SRNE

# of Institutions
15
Shares Held
5.51M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email